LAUSR

1. Newell ML, Bunders MJ. Safety of antiretroviral drugs in pregnancy and breastfeeding for mother and child. Curr Opin HIV AIDS 2013; 8:504–510. 2. Denneman L, Cohen S, Godfried MH, van Leeuwen E, Nellen JFB, Kuijpers TW, et al. In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIVexposed infants. AIDS 2016; 30:2135–2137. 3. Le Roux SM, Abrams EJ, Jao J, Malaba T, Myer T. Response to ‘Inutero exposure to tenofovir is associated with impaired fetal and infant growth’ by Denneman et al. AIDS 2017; 31:595–596. 4. Villar J, Giuliani F, Bhutta ZA, Bertino E, Ohuma EO, Ismail LC, et al. Postnatal growth standards for preterm infants: the Preterm Postnatal Follow-up Study of the INTERGROWTH21(st) Project. Lancet Glob Health 2015; 3:e681–e691. 5. WHO. WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards: Length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: Methods and development. In; 2006 6. Tarantal AF, Castillo A, Ekert JE, Bischofberger N, Martin RB. Fetal and maternal outcome after administration of tenofovir to gravid rhesus monkeys (Macaca mulatta). J Acquir Immune Defic Syndr 2002; 29:207–220. 7. Siberry GK, Williams PL, Mendez H, Seage GR 3rd, Jacobson DL, Hazra R, et al., Pediatric HIV/AIDS Cohort Study (PHACS). Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants. AIDS 2012; 26:1151–1159. 8. Ransom CE, Huo Y, Patel K, Scott GB, Watts HD, Williams P, et al., P1025 Team of the International Maternal Pediatric Adolescent AIDS Clinical Trials Group. Infant growth outcomes after maternal tenofovir disoproxil fumarate use during pregnancy. J Acquir Immune Defic Syndr 2013; 64:374–381. 9. Gibb DM, Kizito H, Russell EC, Chidziva E, Zalwango E, Nalumenya R, et al., DART trial team. Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial. PLoS Med 2012; 9:e1001217. 10. Jacobson DL, Patel K, Williams PL, Geffner ME, Siberry GK, Dimeglio LA, et al., Pediatric HIVAIDS Cohort Study. Growth at two years of age in HIV-exposed uninfected children in the US by trimester of maternal antiretroviral initiation. Pediatr Infect Dis J 2016; Oct 27 [Epub ahead of print].